The ABCs of hemoglobin disorders and pregnancy
November 26, 2024
New Patient Appointment or 214-645-8300
UT Southwestern has unlocked a century-old medical mystery: How does the immune system know when it’s under attack?
September 19, 2024
November 13, 2024
September 25, 2024
November 10, 2022
September 11, 2024
September 13, 2023
June 12, 2023
September 12, 2022
June 16, 2022
For more than 75 years, UT Southwestern has been on a three-part mission: to discover, heal, and educate. As one of the country’s leading academic medical centers, we bring science, determination, and compassion to bear on diseases and conditions that have long vexed humanity.
We’re not content with merely dispensing today’s treatments. We’re searching for breakthroughs in our labs and then moving our discoveries as quickly as possible into new and better treatments for our patients. That’s the science of healing. That’s also the story of UT Southwestern – the future of medicine, today.
A new, hyper-targeted radiation technology could bring your total number of treatments from 45 to just five.
A rare couple in the lab world has developed a new way for surgeons to look at the tumors they need to remove.
Over the last two decades, the world has learned a lot about brain injuries. But now it seems there are more questions than answers.
Most people with depression never get treated. But what if everyone got screened at their regular checkups?
The Science Behind Preventing Teen Suicide
Teens who have attempted suicide are at high risk for a second attempt. But there are ways to help.
New genetic editing technology has opened the door to erasing the mutations in our DNA.
Taking on America's Biggest Killer
Your risk of heart disease could be largely eliminated by mutating just one gene.
What We Know About Your Prostate
Generations of men underwent aggressive screening for prostate cancer. Now doctors are reevaluating just how worried men should be about their prostate.
The Team That's Doubling Cancer Survival Rates
When patients are diagnosed with stage 4 kidney cancer, they have only a 1-in-10 chance of survival. Here, the odds are substantially higher.